Greater Cannabis Company (GCAN) Accumulated Expenses (2016 - 2026)

Greater Cannabis Company's Accumulated Expenses history runs 11 years deep, the most recent figure standing at $500350.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 21.93% year-over-year to $500350.0 in Q1 2026; TTM through Mar 2026 was $500350.0, a 21.93% increase from a year earlier, with the FY2025 full-year figure at $470350.0, up 500.0% from the prior year.
• Accumulated Expenses rose to $500350.0 in Q1 2026 per GCAN's latest filing, from $470350.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $500350.0 in Q1 2026 and bottomed at $42589.0 in Q4 2022.
• The 5-year median for Accumulated Expenses is $311675.0 (2023), against an average of $269012.4.
• Across the five-year window, Accumulated Expenses jumped 28524.08% in 2022 and slumped 79.08% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $42589.0 in 2022, then surged by 30.61% to $55627.0 in 2023, then surged by 40.92% to $78392.0 in 2024, then jumped by 500.0% to $470350.0 in 2025, then rose by 6.38% to $500350.0 in 2026.
• Per Business Quant, the three latest GCAN Accumulated Expenses figures stand at $500350.0 (Q1 2026), $470350.0 (Q4 2025), and $460350.0 (Q3 2025).